Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
385.73
+7.37 (1.95%)
At close: Jul 28, 2026, 4:00 PM EDT
385.50
-0.23 (-0.06%)
After-hours: Jul 28, 2026, 7:39 PM EDT

Elevance Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Net Income
1,4541,7605461,1871,7442,1844131,0082,3012,2498311,3001,8562,0048771,5981,6341,7791,1791,502
Depreciation & Amortization
366354605387380373398329335331424426433462473451393358360351
Stock-Based Compensation
755530848181-2966926272787861736972505963
Other Adjustments
-22-497-37422767164-58-71-863245815326-112197941-98-12455
Change in Receivables
-657-1,174756815-923-3,174-193851-1,059-282-1,035-428-270-29-1,832-16686-1,348-387-119
Changes in Accounts Payable
1,2382,886-2,259-151738952-1,200628557-257-771,55714218226-34204428-374533
Changes in Income Taxes Payable
-156644-284-61624635717357-407581-360-134-448839-297118-727568-2862
Changes in Unearned Revenue
-119266-338270-79132-505312872-2,930-126643,282-2,5902,730-23957195-128
Changes in Other Operating Activities
-263382,455-1,068-200-521,725-663-1,100-1,102721-66169-561,366-32.5388747699-252
Operating Cash Flow
1,9134,332841,1352,0541,0177062,6774471,978-2,9712,6131,9506,469-1,5184,9242,4522,5411,6722,504
Operating Cash Flow Growth (YoY)
-6.87%325.96%-88.10%-57.60%359.51%-48.58%-2.45%-77.08%-69.42%--46.93%-20.47%154.59%-96.65%45.69%1.44%-56.15%-

Investing Activities

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Capital Expenditures
-287-235-293-360-267-196-322-332-323-279-326-319-350-301-298-305-295-254-340-258
Purchases of Investments
-3,132-4,735-2,761-4,163-4,138-3,964-3,280-4,671-3,932-6,1038,101-6,689-10,205-7,443-5,334-6,359-8,203-5,050-3,539-3,909
Proceeds from Sale of Investments
3,4083,6463,2423,4223,8574,5745,4804,4723,1875,433-8,8256,3669,9736,0225,6005,5217,2314,2562,8863,136
Cash Acquisitions
05331504-3,6850-4-1,1201881-13-1,638-26-14-548-61-340
Proceeds from Business Divestments
-------360------------
Other Investing Activities
170-323119-124-189-315205130-145-241105-126-77176347-90-209-46961-409
Investing Cash Flow
159-1,642464-1,224-687103-1,638-401-818-2,310-1,029-687-672-3,184289-1,247-2,024-1,578-966-1,440

Financing Activities

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Short-Term Debt Issued
101724515990--65--1,350225--325090--1,1500
Short-Term Debt Repaid
-825-150-857.5-857.5110-115--75--0---012525225-1,050-450
Net Short-Term Debt Issued (Repaid)
-724574-342.5132.5110-11565-75-1,350225--325021525225100-450
Long-Term Debt Issued
---3---5,1300--0002,5741,785-141,300-00
Long-Term Debt Repaid
0-7503-9000-1,250-850-800---100-1,908-917-39-929-14-114-2
Net Long-Term Debt Issued (Repaid)
0-7500-9000-1,2504,280-800---100666868-53371-14-114-2
Issuance of Common Stock
2637580-2231648609740313843303640764220
Repurchase of Common Stock
-234-1,124-471-876-378-880-1,811-60-463-566-928-480-646-622-568-579-624-545-522-451
Net Common Stock Issued (Repurchased)
-208-1,087-413-876-380-857-1,795-12-403-469-888-449-608-579-538-543-584-469-480-431
Common Dividends Paid
-373-376-377-381-385-386-373-378-378-379-346-348-350-351-305-306-309-309-273-276
Other Financing Activities
-189-8761,056-414347699-709140219-47061668-147-592392-568470889-748329
Financing Cash Flow
-1,494-2,515236243-308-1,9091,408-91566832-394-994-1,430-531-258-1,255-127322-1,315-830

Net Cash Flow

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Foreign Exchange Rate Adjustments
-3-9-6-111-87-5-1-4112-6-6-4-1-2
Net Cash Flow
5751667781531,060-7884681,368292-300-4,393928-1512,755-1,4852,4162951,281-610232

Free Cash Flow

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
1,6264,097-2097751,7878213842,3451241,699-3,2972,2941,6006,168-1,8164,6192,1572,2871,3322,246
Free Cash Flow Growth (YoY)
-9.01%399.03%--66.95%1341.13%-51.68%-2.22%-92.25%-72.45%--50.34%-25.82%169.70%-105.65%54.29%-0.61%-62.32%-
FCF Margin
3.26%8.28%-0.42%1.55%3.62%1.68%0.85%5.24%0.29%4.02%-7.77%5.40%3.69%14.72%-4.58%11.66%5.61%6.04%3.70%6.32%
Free Cash Flow Per Share
7.4618.59-0.943.467.913.611.6610.060.537.25-13.989.706.7325.73-7.5319.078.869.365.439.13
Levered Free Cash Flow
1,5185,54190.5-1,1172,6712,3845,0324721,3702,942-1,4682,0321,7637,224612.54,6931,7573,9041,6891,365
Unlevered Free Cash Flow
2,0205,461254.23-581.482,5513,920604.991,2751,0761,565-1,6621,9571,7406,230-271.194,4501,4033,6774,8021,755
SEC Filings: 10-K · 10-Q